EFFECT OF ACLIDINIUM/FORMOTEROL ON LUNG HYPERINFLATION, EXERCICE CAPACITY AND PHYSICAL ACTIVITY IN MODERATE TO SEVERE COPD PATIENTS

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Aclidinium/Formoterol;   Drug: Placebo
Sponsors:   AstraZeneca;   Menarini (Co-Funder)
Not yet recruiting – verified April 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days